Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | MAPT | P10636 | 3/20 | 0.59 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.59 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.59 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.59 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.59 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.56 |
| ▸ | CDC25A | P30304 | 1/20 | 0.55 |
| ▸ | CDC25B | P30305 | 1/20 | 0.55 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.53 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.53 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.53 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.53 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.53 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.53 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.53 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4624978 | 1.00 | ALDH1A1 (0.59) | ALDH1A1MAPTHDAC1HDAC3HDAC2 | |
| SCHEMBL19816482 | 1.00 | ALDH1A1 (0.59) | ALDH1A1MAPTHDAC1HDAC3HDAC2 | |
| SCHEMBL19816825 | 1.00 | ALDH1A1 (0.59) | ALDH1A1MAPTHDAC1HDAC3HDAC2 | |
| SCHEMBL8390655 | 1.00 | ALDH1A1 (0.59) | ALDH1A1MAPTHDAC1HDAC3HDAC2 | |
| SCHEMBL16691726 | 1.00 | ALDH1A1 (0.59) | ALDH1A1MAPTHDAC1HDAC3HDAC2 | |
| SCHEMBL15068944 | 1.00 | ALDH1A1 (0.59) | ALDH1A1MAPTHDAC1HDAC3HDAC2 | |
| Water SCHEMBL28193859 | 0.98 | HDAC1 (0.57) | ALDH1A1MAPTHDAC1HDAC3HDAC2 | |
| SCHEMBL6130488 | 0.98 | MAPT (0.61) | ALDH1A1MAPTHDAC1HDAC3HDAC2 | |
| SCHEMBL2177141 | 0.92 | ALDH1A1 (0.64) | ALDH1A1MAPTHDAC1HDAC3HDAC2 | |
| SCHEMBL27591545 | 0.90 | ALDH1A1 (0.61) | ALDH1A1MAPTHDAC1HDAC3HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018100089-A1 | MEANS AND METHODS FOR VISUALIZATION OF TISSUE STRUCTURES | GRETZ NORBERT (DE) | 2018-06-07 | — | — | WO | disclosed |
| EP-3077501-A1 | MICROORGANISMS AND METHODS FOR IMPROVING PRODUCT YIELDS ON METHANOL USING ACETYL-COA SYNTHESIS | Genomatica, Inc. (US) | 2016-10-12 | — | — | EP | disclosed |
| WO-2015084633-A1 | MICROORGANISMS AND METHODS FOR IMPROVING PRODUCT YIELDS ON METHANOL USING ACETYL-COA SYNTHESIS | GENOMATICA, INC. (US) | 2015-06-11 | — | — | WO | disclosed |
| EP-2129788-B1 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS LLC (US) | 2014-09-03 | — | — | EP | disclosed |
| WO-2014041424-A1 | HISTONE DEACETYLASE INHIBITORS FOR ENHANCING ACTIVITY OF ANTIFUNGAL AGENTS | METHYLGENE INC. (CA) | 2014-03-20 | — | — | WO | disclosed |
| US-8642014-B2 | Luminescent compounds | SETA BIOMEDICALS, LLC (US) | 2014-02-04 | — | — | US | disclosed |
| EP-2432893-A1 | COMPOSITIONS, KITS AND METHODS FOR IN VITRO ANTIGEN PRESENTATION, ASSESSING VACCINE EFFICACY, AND ASSESSING IMMUNOTOXICITY OF BIOLOGICS AND DRUGS | University Of Miami (US) | 2012-03-28 | — | — | EP | disclosed |
| WO-2010135394-A1 | COMPOSITIONS, KITS AND METHODS FOR IN VITRO ANTIGEN PRESENTATION, ASSESSING VACCINE EFFICACY, AND ASSESSING IMMUNOTOXICITY OF BIOLOGICS AND DRUGS | UNIVERSITY OF MIAMI (US) | 2010-11-25 | — | — | WO | disclosed |
| US-20100266507-A1 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS, LLC | 2010-10-21 | — | — | US | disclosed |
| EP-2129788-A2 | LUMINESCENT COMPOUNDS | Seta Biomedicals, LLC (US) | 2009-12-09 | — | — | EP | disclosed |
| EP-1910524-A4 | MODULATION OF SPHINGOSINE KINASE SIGNALLING | MEDVET SCIENCE PTY LTD (AU) | 2009-04-01 | — | — | EP | disclosed |
| WO-2008094637-A2 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS. LLC (US) | 2008-08-07 | — | — | WO | disclosed |
| EP-1910524-A1 | MODULATION OF SPHINGOSINE KINASE SIGNALLING | MEDVET SCIENCE PTY. LTD. (AU) | 2008-04-16 | — | — | EP | disclosed |
| EP-1781695-A1 | SELECTIVE VPAC2 RECEPTOR PEPTIDE AGONISTS | ELI LILLY AND COMPANY (US) | 2007-05-09 | — | — | EP | disclosed |
| WO-2006135968-A1 | MODULATION OF SPHINGOSINE KINASE SIGNALLING | MEDVET SCIENCE PTY. LTD. (AU) | 2006-12-28 | — | — | WO | disclosed |
| WO-2006023367-A1 | SELECTIVE VPAC2 RECEPTOR PEPTIDE AGONISTS | ELI LILLY AND COMPANY (US) | 2006-03-02 | — | — | WO | disclosed |
| WO-2001055441-A2 | NUCLEIC ACIDS, PROTEINS, AND ANTIBODIES | HUMAN GENOME SCIENCES, INC. (US) | 2001-08-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100266507-A1 | LUMINESCENT COMPOUNDS | SQLE, COASY, ZKSCAN2 | ALDH1A1 2552/4885MAPT 4099/4885HDAC1 3212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.